National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

tecogalan sodium
A sulfated polysaccharide isolated from various Arthrobacter bacterial species. Possessing potential antiangiogenic and antineoplastic properties, tecogalan binds to basic fibroblast growth factor (bFGF), thereby preventing bFGF from binding to its receptors. Disruption of this receptor binding results in the inhibition of bFGF-stimulated endothelial cell growth, proliferation, and migration. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Sulfated Polysaccharide Tecogalan DS-4152
Abbreviation:SP-PG
Code name:DS-4152



Previous:Tazorac, TechneScan MDP, technetium Tc 94m sestamibi, technetium Tc 99m methylene diphosphonate, technetium Tc 99m sulfur colloid
Next:tegafur, tegafur-uracil, Tegretol, teicoplanin, TELCYTA

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov